Kardigan

Drug Discovery · South San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a heart health company intended to modernize cardiovascular drug development. Kardigan is based in South San Francisco, CA and was founded in 2023. It is valued at about $646 million as of Oct 2026, set by institutional fund marks. It has raised $554 million across 1 recorded round; the latest was a $254 million Series B in Oct 2025.

PMV mark · valuation
$646.0M
Oct 2026
Priced at
—
Total raised
$554.0M
Last round
Early Stage VC (Series B)
Oct 2025
Cap table — not yet on record

Kardigan's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Kardigan
  • ·6 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Frequently asked about Kardigan

Where does Kardigan's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Kardigan's 1 recorded funding rounds.